Barclays Maintains Overweight on Astera Labs, Lowers Price Target to $70
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Tom O'Malley maintains an Overweight rating on Astera Labs (NASDAQ:ALAB) but lowers the price target from $85 to $70.
August 07, 2024 | 4:34 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays analyst Tom O'Malley maintains an Overweight rating on Astera Labs but lowers the price target from $85 to $70.
The Overweight rating suggests a positive outlook, but the lowered price target indicates some concerns or adjustments in expectations. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100